Company Management

Emmecell

Biotechnology Research 3475 Edison Way 11 employees

Employees: 11
Contacts: 1
Emails: 1

emmecell.com LinkedIn

Emmecell Overview

Headquarters: 3475 Edison Way
Website: emmecell.com
Industry: Biotechnology Research
Employees: 11
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology Ophthalmology Cell Therapy Nanotechnology Magnetic Cell Delivery Clinical Trials cGMP Manufacturing

About Emmecell

Emmetrope Ophthalmics LLC, (aka “Emmecell”) is a privately-held, clinical stage biotechnology company developing cell-based therapies. Emmecell’s platform technology leverages magnetic nanoparticles to effectively localize and integrate cell therapies to the appropriate target tissue. Our lead product EO2002 is a cell therapy for treatment for corneal edema, the most common indication for corneal transplantation. Cell Manufacturing and Production LLC (CellMP) was founded in 2018 and is a subsidiary of Emmecell providing GMP manufacturing services in Menlo Park, CA.

Emmecell Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

Emmecell Org Chart

Sample employees and titles

Name	Title	Location	Contact
Christy Fleming	Director of Clinical Operations	Charlotte Metro, United States	Email
Kalisse Ajlouny	Research Associate at Emmecell B.s		View
Cyril Allouche, CFO, Mba, Cpa	Working with Boards for Over 28 Years	San Francisco, California, United States	View
Rain Wen, Phd	Founder of Milkomeda Capital; Biotech	San Francisco Bay Area, United States	View